---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009330"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2025-03-06T23:59:59+00:00"
generated_at: "2026-05-25T07:40:00.293152+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharmaceuticals receives Nasdaq extension, plans transfer to Capital Market

## Summary
- Nasdaq Hearing Panel granted extension to March 31, 2025 to regain MVPHS and MVLS compliance.
- Company must file application to transfer to Nasdaq Capital Market by March 12, 2025.
- Bid Price compliance regained as of February 26, 2025; extension conditional on meeting all listing rules.
- Company believes it can satisfy equity standard of >$2.5M stockholder's equity before deadline.

## SEC filing metadata
- accession: 0001493152-25-009330
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2025-03-06T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315225009330/0001493152-25-009330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315225009330/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009330
- JSON: https://secwatch.observer/filing/0001493152-25-009330.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009330.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.